Pulmonary lesions following inoculation with the SARS-CoV-2 Omicron BA.1 (B.1.1.529) variant in Syrian golden hamsters시리아 골든 햄스터에서 SARS-CoV-2 Omicron BA.1(B.1.1.529) 변종 접종 후 폐 병변Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, [키워드] animals B.1.1.529 B.1.617.2 characterized Clinical signs COVID-19 disease decrease Delta Disease progression disease severity evaluate Evidence evidence of golden hamster hamster hamsters histopathological Human Immune escape Immunity Infection inoculated intrinsic Kinetics lesion Mutation omicron Omicron BA.1 pathogenicity pathological changes pathology Pneumonia pre-existing immunity progression pulmonary re-challenge. reduced SARS-CoV-2 SARS-CoV-2 variant Syrian golden hamster the SARS-CoV-2 vaccination variant viral genome viral shedding viral spread virus [DOI] 10.1080/22221751.2022.2095932 PMC 바로가기 [Article Type] Article
Pulmonary delivery of favipiravir inhalation solution for COVID-19 treatment: in vitro characterization, stability, in vitro cytotoxicity, and antiviral activity using real time cell analysisArticle Published on 2022-12-012022-11-15 Journal: Drug Delivery [Category] COVID19(2023년), SARS, 치료제, [키워드] addition administration Analysis Antiviral antiviral activity Calu-3 Cell characterized Concentration COVID-19 cytotoxicity Favipiravir in vitro indicated Influenza virus Inhaled inhaled formulation inhibitor investigated lung lung epithelial cell lung tissue Lungs media Patient patients with COVID-19 PBS phosphate buffer profile pulmonary RdRP real time required respiratory. RNA-dependent RNA polymerase SARS-CoV-2 stability target Toxicity treat Treatment VERO-E6 viability were infected [DOI] 10.1080/10717544.2022.2118398 PMC 바로가기
Mortality and Deep Vein Thrombosis in the Gamma Variant of Covid 19 and Lung InjuryArticle Published on 2022-11-032022-11-16 Journal: Vascular Health and Risk Management [Category] SARS, 변종, [키워드] affecting Analysis chi-square test clinical suspicion Coagulation complications conducted COVID-19 Critically ill patient deep Deep vein Deep vein thrombosis determine DVT Factor Fisher Gamma greater had more hospital infected individual inhibitor intensive care involved lesion less lung mechanism medical record Mortality occurred Patient patients with SARS-CoV-2 positive Prevalence pulmonary pulmonary injury Pulmonary thrombosis. Retrospective study SARS-CoV-2 disease severe lung injury t -test thrombosis thrombotic event Treatment two group variant Vein Venous thrombosis [DOI] 10.2147/VHRM.S367930 PMC 바로가기
Central Retinal Vein Occlusion After Discontinuation of Rivaroxaban Therapy in a Young Patient with COVID-19 Pulmonary Embolism: A Case ReportArticle Published on 2022-11-012022-11-15 Journal: The American journal of case reports [Category] 진단, [키워드] anticoagulation Combination common contributing to Convalescent plasma therapy Course COVID-19 decrease Dexamethasone diagnosed discharge edema Factor healthy Hospitalized hypercoagulability initiated intravitreal injection knowledge occurred Oxygen therapy Patient Prophylactic pulmonary rebound Remdesivir report retinal vein retinal vein occlusion rivaroxaban Severe COVID-19 pneumonia significantly subsegmental the patient therapeutic therapy treated Treatment visual acuity was performed were excluded with COVID-19 [DOI] 10.12659/AJCR.937739 PMC 바로가기
SARS-CoV-2 antibody research in patients with unprovoked pulmonary embolism in COVID-19 pandemic periodArticle Published on 2022-11-012022-11-16 Journal: Journal of Thrombosis and Thrombolysis [Category] SARS, 치료기술, [키워드] addition antibody Antigen Asymptomatic COVID-19 asymptomatic patients checked Computed tomography consecutive patient coronavirus coronavirus disease COVID-19 COVID-19 infection COVID-19 pandemic CTPA diagnosed Elderly patient had no Immunity increase in material pandemic participant Patient patients patients with comorbidity PE positive result pulmonary Pulmonary thromboembolism Research risk risk factor SARS-CoV-2 SARS-CoV-2 antibody serum sample significant increase the patient thrombosis Tomography. were measured [DOI] 10.1007/s11239-022-02703-8 PMC 바로가기
Accuracy of quality of life questionnaire as a diagnostic tool for SARS-CoV-2 pulmonary sequelaeArticle Published on 2022-10-142022-11-16 Journal: Medicina clínica [Category] COVID19(2023년), SARS, 치료기술, [키워드] age alteration alterations AUC Cardiopulmonary Covid persistente COVID-19 CPET Cuestionario de calidad de vida SF-12 detect diagnostic domain English female first positive follow-up study functional Healthcare system hospital discharge Hospitalization identify Long Long COVID maximum oxygen consumption media Patient PCR performed physical predicted primer Prospective prospectivo Prueba de esfuerzo cardiopulmonar Pruebas funcionales respiratorias pulmonary Pulmonary function Pulmonary function test Quality of life questionnaire reduced SARS-CoV-2 Sensitivity and specificity SF-12 quality of life questionnaire. significantly Spanish survivor Symptom Symptoms utility [DOI] 10.1016/j.medcli.2022.02.007 PMC 바로가기
Pulmonary Involvement in SARS-CoV-2 Infection Estimates Myocardial Injury RiskArticle Published on 2022-10-112022-11-15 Journal: Medicina [Category] COVID19(2023년), SARS, 바이오마커, [키워드] acute respiratory syndrome Admission age Alpha alveolar ambient biochemical biochemical marker Biomarker C reactive protein can be used cardiac injury chest scan Computerized tomography consecutive patients consolidation coronavirus correlated correlation COVID-19 COVID-19 complications COVID-19 patient COVID-19 risk factors CRP CT scan Diastolic blood pressure dysfunction elevated estimate Factor Factors fibrinogen group Hospitalization IL-6 Infection Inflammatory marker Injury interleukin-6 interlobular septal thickening interstitial Involvement lactate dehydrogenase LDH lesion lung Lung disease lung involvement material multisystemic myocardial injury myocardial injury. myocardial involvement Myoglobin Necrosis non-specific NT-proBNP objective Observational cohort study occurred parameters pathology Patient Patient care performed peripheral oxygen saturation Pneumonia pulmonary pulmonary involvement pulmonary lobe radiological Registered respiratory rate respiratory rates Result risk routine SARS-CoV-2 SARS-COV-2 infection Serum ferritin severity Sex significant difference Systolic blood pressure the disease the patient the study group TnI [DOI] 10.3390/medicina58101436 PMC 바로가기
Pulmonary rehabilitation in post-discharge treatment of patients with COVID-19 pneumoniaCorrespondence Published on 2022-10-012022-10-05 Journal: Asian journal of surgery [Category] COVID19(2023년), SARS, 치료법, [키워드] patients with COVID-19 Pneumonia pulmonary rehabilitation Treatment [DOI] 10.1016/j.asjsur.2022.04.066 [Article Type] Correspondence
ASSOCIATION OF TNF-α, TGF-β1, AMPHIREGULIN, IL-2, AND EGFR WITH PULMONARY FIBROSIS IN COVID-19Short communication Published on 2022-10-012022-10-05 Journal: Journal of infection and public health [Category] 바이오마커, [키워드] age analyzed association blood sample chest CT scan coronavirus disease COVID-19 COVID-19 pneumonia patient Critical cytokine discharged EGFR ELISA evaluate evaluated fibrosis hospital IL-2 mechanism men Patient Pneumonia pulmonary pulmonary fibrosis Serum level severity TGF TGF-β1 the patient TNF- α TNF-α was performed women [DOI] 10.1016/j.jiph.2022.08.007 [Article Type] Short communication
Imaging of Pulmonary Superinfections and Co-Infections in COVID-19Review article Published on 2022-09-012022-10-05 Journal: Current problems in diagnostic radiology [Category] SARS, 바이오마커, [키워드] aerosol generating procedure Co-infection COVID-19 Diagnosis feature globe help highlight imaging increase Infection Limited management New organism overlap pandemic patient group patients with COVID-19 Pneumonia pulmonary radiologist respiratory sample superinfection [DOI] 10.1067/j.cpradiol.2021.09.009 [Article Type] Review article